The antiphospholipid syndrome is characterized by clinical evidence of arterial or venous thrombosis, thrombocytopaenia, recurrent fetal loss and repeated positivity of antiphospholipid autoantibodies. The association of antiphospholipid syndrome with the development of adrenal failure has been reported in more than 40 patients in the last 20 years, mostly due to bilateral cortical haemorrhage or thrombosis of adrenal vessels. The presence of antibodies against adrenal cortex was never documented in these patients. Here we report a case of recurrent thrombophlebitis, acute adrenal failure, and chronic hepatitis occurring in a young man found to have antiphospholipid antibodies and lupus anticoagulant. Autoantibodies against adrenal cortex were detected and abdominal ultrasonography showed morphologically normal adrenals. Mild thrombocytopaenia, Coomb's positive anaemia, increase in alanine-and aspartate-aminotransferases and increase in urinary protein excretion were found. Autoantibodies against liver/kidney microsomes were positive and liver biopsy was compatible with autoimmune hepatitis. The patient was treated with cortisone acetate, fludrocortisone and warfarin. Dilated cardiomyopathy was revealed one year later and coronarography did not document any occlusive coronary disease. Three years later, titres of autoantibodies, including those directed towards the adrenal cortex, were increased and others, previously absent, were detected. Nevertheless, the patient's clinical conditions seemed unchanged. At this time, an abdominal CT scan showed adrenal dysmorphisms with bilateral annular calcifications and central hypodensities suggesting previous bilateral adrenal haematomas. The hypercoagulable state that occurs in antiphospholipid syndrome can induce a localized inflammatory response generated by tissue injury, with a consequent release of intracellular antigens and antibodies production. Consequently, tissue-specific autoantibodies positivity may persist until the cells involved in antigen production are completely destroyed.
Introduction
The antiphospholipid syndrome is characterized by clinical evidence of arterial or venous thrombosis, thrombocytopaenia, recurrent fetal loss and repeated positivity of at least one serological test for antiphospholipid autoantibodies (aPL) (1, 2) . The antiphospholipid antibodies comprise different families of autoantibodies reacting with a variety of phospholipids, including cardiolipin, reagin, neutral or anionic phospholipids, ligands containing phospholipid, and lupus anticoagulant phenomenon. Recently, almost all families of autoantibodies were detected in the same individual (2) . The presence of aPL induces a hypercoagulable state associated with a variety of clinical complications. Deep vein thrombosis, pulmonary embolism and cerebrovascular thromboembolism are the most common; however, virtually any vein, artery or small vessel may be occluded in aPL positive patients (2) . Involvement of abdominal aorta, mesenteric veins and arteries, hepatic and renal arteries, veins and small vessels, and myocardial vessels has been described resulting in organ dysfunction such as renal infarction, glomerular vasculopathy, Budd-Chiari syndrome, myocardial infarction or vascular 'cardiomyopathy' (2, 3) . In addition, in some patients, other complications including chorea, Guillain-Barrè syndrome, organic brain syndromes, haemolytic anaemia, cardiac valvular lesions and skin lesions have also been described (2, 3) . The association of antiphospholipid syndrome with the development of adrenal failure was first described in 1980 (4), and since then this relationship has been reported in more than 40 patients (2). Bilateral adrenal haemorrhage or thrombosis of adrenal vessels have been documented in several of these cases and haemorrhagic infarction secondary to thrombosis of adrenal veins has been suspected in others (2) . Nevertheless, the pathogenesis of adrenal failure often remains unclear. However, the presence of autoantibodies against adrenal cortex has never before been demonstrated in aPL positive patients affected by adrenal failure (2). Here we report a case of adrenal failure, dilated cardiomyopathy and chronic hepatitis occurring in a patient with aPL antibodies and lupus anticoagulant.
Case report
In March 1993, a 27-year-old man developed abdominal pain, nausea, weight loss, weakness and hypotension one week after a 5-day episode of fever >38.5 ЊC. He had a previous history of acute arthritis at the age of 8 years and recurrent thrombophlebitis of the lower limbs treated with antibiotics but never by anticoagulant drugs before the age of 24 years. There was no family history of endocrine, autoimmune or coagulation disorders.
The patient was admitted to his town hospital, and the haematochemical evaluation showed normochromic anaemia (Hb: 10 g/dl), mild thrombocytopaenia (100 000 per microlitre), increase in urinary protein excretion (200 mg/day), increase in alanine-and aspartate-aminotransferases (75 and 80 U/l respectively), low serum sodium (124 mEq/l) and normal potassium (4.6 mEq/l) levels. Negative markers for hepatitis A, B and C and positive venereal disease research laboratory test (VDRL) were found. However, antibodies against Treponema pallidum by an indirect immunofluorescence method were absent. Therefore, the false positive VDRL was probably due to the presence of antibodies directed against the phospholipid reagin (5). Plasma cortisol was 1.1 mg/dl (30.3 nmol/l; normal, 5 to 20 mg/dl) and adrenocorticotrophin (ACTH) was 450 pg/ml (99 pmol/l; normal, 5-90 pg/ml) at 0800 h. The diagnosis of adrenal insufficiency was made and regular oral cortisone acetate therapy was started (37.5 mg daily).
One month later the patient was admitted to our hospital because of persistent asthaenia and hypotension. His height was 170 cm and body weight 50 kg. Arterial pressure was 65/45 mm Hg and the pulse rate was 98/min. The remaining physical examination was negative except for mild hepatomegaly. No hyperpigmentation was observed. Haematochemical studies and endocrine assays confirmed the previous results, moreover Coomb's positive anaemia and mild hypercalcaemia were revealed (Table 1) . Abdominal ultrasonography showed an increased echogenicity of morphologically normal adrenals. Autoantibodies to liver/kidney microsomes were detected by ELISA assays. Autoantibodies raised against adrenal cortex (ACA) were detected by a conventional indirect immunofluorescence method (6), using unfixed cryostat sections of normal monkey adrenal gland. Fluorescein isothiocyanate-conjugated rabbit antihuman immunoglobulin G (IgG) serum (Dako, Milan, Italy) diluted 1:40, was used to detect the presence of ACA reacting with adrenal antigens. Complement-fixing ACA were detected with rabbit fluorescein isothiocyanate serum antihuman C3 (Dako) at a 1:40 dilution as previously described (6) . Activated partial thromboplastin time was prolonged and did not normalize after the addition of normal plasma thus revealing that it was not caused by insufficient and/or altered production of coagulation factors. The presence of lupus anticoagulant was detected by phospholipid-dependent coagulation assays in citrated plasma obtained after double centrifugation. Kaolin clotting time (KCT, laboratory kit), dilute Russell's viper venom time (DRVVT; ORTHO Diagnostics, Milan, Italy) and a partial thromboplastin time (APTT), using a reagent with low phospholipid content (APTT-LA, Boehringer Mannheim Italia, Milan, Italy), were performed. Anticardiolipin autoantibodies (aCL) were positive. Other autoantibodies and antibodies to Mycobacterium tuberculosis were negative. Oral cortisone acetate was replaced by intravenous hydrocortisone therapy (200 mg daily) and oral anticoagulant treatment was started. The patient gradually recovered with resolution of weakness and hypotension. One week later he was discharged from the hospital, while taking cortisone acetate 50 mg, fludrocortisone 0.1 mg daily and warfarin. The international normalized ratio (INR) of prothrombin time was maintained in the range 2-3. The diagnosis was autoimmune Addison's disease, antiphospholipid syndrome and probable autoimmune hepatitis type 2. Eleven months later, dilated cardiomyopathy was diagnosed and treatment with antiarrhythmics, calcium antagonists and diuretics was begun. Coronarography failed to reveal occlusive coronary disease. The patient's liver enzyme levels were still slightly increased and urinary protein excretion ranged from 150 to 512 mg/day. Liver biopsy showed moderate mononuclear portal infiltrate, mild steatosis and fibrosis, findings suggesting autoimmune hepatitis (7) .
The patient returned after three years, in January 1997. His clinical conditions were unchanged although many autoantibodies previously negative had became positive and the titres of others, already positive in 1993, had increased. The patient was still taking cortisone acetate 37.5 mg, fludrocortisone 0.1 mg daily and warfarin (INR 2-3). Abdominal CT scan showed mild hepatomegaly without focal lesions. Both adrenals appeared moderately dysmorphic, containing annular calcifications with central hypodensities (Fig. 1) , features consistent with previous bilateral haemorrhage (8, 9) . The patient had always had normal function of the remaining endocrine glands, and other endocrine organ-specific autoantibodies were never detected. Lupus erythematosus and autoimmune vasculitis were ruled out on the basis of clinical symptoms and laboratory findings.
The results of endocrine, haematochemical and immunological studies in March 1993, February 1994 and January 1997 are summarized in Table 1 .
Discussion
The association of antiphospholipid autoantibodies with thrombotic events is well established (1-4, 10) . Antiphospholipid syndrome may occur in a variety of conditions including connective tissue disorders, some neoplasms and infections, and during administration of several drugs, or it can be found without any demonstrable underlying disease (1, 10). The incidence and mechanism of adrenal failure in association with an antiphospholipid syndrome remain unclear. In most reported cases adrenal failure has been ascribed to bilateral haemorrhage. Several authors suggested that, for anatomical reasons, adrenal haemorrhage might follow multiple thromboses of adrenal veins, and would be a secondary event (11) . Other thromboembolic events had preceded or followed the adrenal haemorrhage in the reported patients and ACA were absent in all of them (3, 4, 10) . On the other hand, anticoagulant therapy has been considered a precipitating factor for adrenal haemorrhage in several patients (2, 9). In the patient described here, a CT scan in January 1997 showed adrenal calcifications, possibly due to previous bilateral adrenal haematomas, which were not evident at abdominal ultrasonography in March 1993, when the clinical features of acute adrenal failure were already present. This would not be consistent with a haemorrhagic etiopathogenesis of the adrenal failure. Adrenal haemorrhage manifests itself as a round or oval adrenal mass that decreases in both size and CT density with time (8, 9, 11) . However, the sensitivity of ultrasound and CT to detect adrenal masses is reported to be 87% and 93% respectively, and a close correlation is also found between the sizes measured by both imaging procedures (12, 13) . Therefore, the ability of the two techniques to detect adrenal haematomas is similar. Nevertheless, we cannot rule out anticoagulant therapy as a cause of adrenal haemorrhage, but not of adrenal failure since this treatment started several weeks after the diagnosis of adrenal insufficiency had been made.
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Unusual multiorgan autoimmune injury 643 The presence of ACA suggests an autoimmune mechanism of the adrenal failure in this patient. ACA are regarded as sensitive markers of the autoimmune form of adrenal failure (6, 14) . Although their role in the primary pathogenic response is unclear, it is likely that they arise as a consequence of T-cell-mediated tissue damage, which seems to be a major event in the pathogenesis of adrenal failure. ACA seem to be produced as a secondary response against intracellular antigens like enzymes (P450c21, P450c17 and P450scc) released from the damaged gland, which are, in normal conditions, sequestered from the immune system (15) (16) (17) . Plasma ACA may disappear several years after the onset of Addison's disease (14) . Interestingly, in this patient, the titres of ACA and other autoantibodies did not decrease after the onset of clinical diseases, but arose in the following three years. Autoimmune Addison's disease is also frequently associated with other endocrine organ-specific autoimmune diseases (14-16) which were, however, never detected in this patient.
Despite ACA positivity that strongly suggests an autoimmune adrenalitis, vascular injury, perhaps bilateral thromboses, cannot be excluded as the cause of the acute adrenal failure. In fact, ischaemia/reperfusion damage of various organs including adrenal cortex and myocardium is associated with both apoptosis and/or necrosis (18) that may induce the release of intracellular antigens and activation of autoantibodies production (18) (19) (20) . However, in both cases the hypercoagulable state that occurs in the antiphospholipid syndrome can induce a localized inflammatory response generated by tissue injury, with a consequent release of cytokines and chemoattractants for macrophages, lymphocytes, and non-specific inflammatory cells. The local concentration of the immune system cells could favour the interaction between antigen presenting cells (APCs) and T-and Blymphocytes that induce the production of autoantibodies. Specific antigens can be continuously produced in the injured tissue and a decrease in the immune response occurs only when the cells involved in the antigen production are completely destroyed. Consequently, tissue-specific autoantibodies positivity may persist in patients susceptible to autoimmune diseases. Antiphospholipid autoantibodies may also be involved in the pathogenesis of dilated cardiomyopathy. Several authors have demonstrated histologically multiple thromboses of small coronary vessels in patients with aPL and hypokinesis of the left ventricle in the absence of clear myocardial infarction, resulting in a condition known as 'pseudocardiomyopathy' (21).
In conclusion, this report is the first describing (i) the association of antiphospholipid syndrome and autoimmune adrenalitis and (ii) the increase in ACA titres after the onset of overt adrenal failure in a patient with clinical manifestations probably reflecting multiorgan autoimmune injury.
